The innate immune system coordinates the inflammatory response to pathogens. To do so, cells of the innate immune system must rapidly discriminate between self and non-self. All bacteria express membrane-associated lipoproteins. These molecules activate cells of the innate immune system to initiate host defense mechanisms. However, it is currently unknown how the innate immune system recognizes bacterial lipoproteins. Here, we describe that in response to bacterial lipoprotein, human Toll-like receptor-2 activates three different cellular responses: nuclear factor-κB dependent transcription, programmed cell death and reactive oxygen species production. We propose that Toll-like receptor-2 fulfils multiple roles in the genesis of the immune response to bacterial pathogens.
References
1.
Medzhitov R. , Janeway Jr CA. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol1997; 9: 4—9.
2.
Henderson B. , Poole S., Wilson M.Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev1996; 60: 316—341.
3.
Medzhitov R. , Janeway Jr CA. Innate immunity: the virtues of a nonclonal system of recognition. Cell1997; 91: 295—298.
4.
Norgard MV, Arndt LL, Akins DR, Curetty LL, Harrich DA, Radolf JDActivation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B. Infect Immun1996; 64: 3845—3852.
5.
Kreutz M., Ackermann U., Hauschildt S. et al. A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccous aureus in human monocytes. Immunology1997 ; 92: 396—401.
6.
Bessler WG, Cox M., Lex A., Suhr B., Wiesmuller KH, Jung G.Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J Immunol1985; 135: 1900—1905.
7.
Rock FL, Hardiman G., Timans JC, Kastelein RA, Bazan JFA family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA1998; 95: 588—593.
8.
Lemaitre B., Nicolas E., Michaut L., Reichhart JM, Hoffmann JAThe dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell1996; 86: 973—983.
9.
O'Neill LA, Greene C.Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol1998; 63: 650—657.
10.
Yang RB, Mark MR, Gray A. et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature1998; 395: 284—288.
Poltorak A. , He X., Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science1998; 282: 2085—2088.
13.
Shimazu R., Akashi S., Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med1999; 189: 1777—1782.
14.
Hirschfeld M., Ma Y., Weis JH, Vogel SN, Weis JJCutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol2000; 165: 618—622.
15.
Goldman RC, White D., Leive L.Identification of outer membrane proteins, including known lymphocyte mitogens, as the endotoxin protein of Escherichia coli 0111. J Immunol1981; 127: 1290—1294.
16.
Zhang H., Peterson JW, Niesel DW, Klimpel GRBacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J Immunol1997; 159: 4868—4878.
17.
Aliprantis AO, Yang RB, Mark MR et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science1999; 285: 736—739.
18.
Horejsi V., Hilgert I., Kristofova H., Bazil V., Bukovsky A., Kulhankova J.Monoclonal antibodies against human leucocyte antigens. I. Antibodies against beta-2-microglobulin, immunoglobulin kappa light chains, HLA-DR-like antigens, T8 antigen, T1 antigen, a monocyte antigen, and a pan-leucocyte antigen. Folia Biol1986; 32: 12—25.
19.
Dentener MA, Bazil V., Von Asmuth EJ, Ceska M., Buurman WAInvolvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol1993; 150: 2885—2891.
20.
Iovine NM, Elsbach P., Weiss J.An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc Natl Acad Sci USA1997; 94: 10973—10978.
21.
Zhang FX, Kirschning CJ, Mancinelli R. et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem1999; 274: 7611—7614.
22.
Baichwal VR, Baeuerle PAActivate NF-kappa B or die?Curr Biol1997 ; 7: R94—R96.
Palombella V., Rando OJ, Goldberg AL, Maniatis T.The ubiquitin-proteasome pathway is required for processing the NFκB1 precursor protein and the activation of NF-κB . Cell1994; 78: 773—785.
25.
Wang CY, Mayo MW, Baldwin Jr ASTNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB . Science1996; 274: 784—787.
26.
Delic J., Masdehors P., Omura S. et al. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br J Cancer1998; 77: 1103—1107.
27.
Segal AW, Shatwell KPThe NADPH oxidase of phagocytic leukocytes. Ann NY Acad Sci1997; 832: 215—222.
28.
Sellati TJ, Bouis DA, Kitchens RL et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J Immunol1998; 160: 5455—5464.
29.
Pugin J., Heumann ID, Tomasz A. et al. CD14 is a pattern recognition receptor. Immunity1994; 1: 509—516.
30.
Ulevitch RJ , Tobias PSRecognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol1999; 11: 19—22.
31.
Wooten RM, Morrison TB, Weis JH, Wright SD, Thieringer R., Weis JJThe role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol1998; 160: 5485—5492.
Ashkenazi A. , Dixit VMDeath receptors: signaling and modulation . Science1998; 281: 1305—1308.
34.
Zychlinsky A., Sansonetti P.Apoptosis in bacterial pathogenesis. J Clin Invest1997; 100: 493—495.
35.
Savill J.Apoptosis in resolution of inflammation. J Leukoc Biol1997; 61: 375—380.
36.
Bessler WG, Heinevetter L., Wiesmuller KH et al. Bacterial cell wall components as immunomodulators. I. Lipopeptides as adjuvants for parenteral and oral immunization. Int J Immunopharmacol1997; 19: 547—550.
37.
Matzinger P.An innate sense of danger. Semin Immunol1998; 10: 399—415.
38.
Irani K., Goldschmidt-Clermont PJRas, superoxide and signal transduction. Biochem Pharmacol1998; 55: 1339—1346.
